| scholarly article | Q13442814 |
| P2093 | author name string | Domenico Praticò | |
| Jian-Guo Li | |||
| P2860 | cites work | Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. | Q48492184 |
| MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice | Q49051978 | ||
| Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. | Q52271466 | ||
| Lifelong management of amyloid-beta metabolism to prevent Alzheimer's disease. | Q53441656 | ||
| Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins | Q68921833 | ||
| Cerebral amyloid angiopathy | Q83826066 | ||
| Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
| Homocysteine and Alzheimer's disease | Q28185747 | ||
| Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
| Structure of cerebral arterioles in cystathionine beta-synthase-deficient mice | Q28590182 | ||
| LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β. | Q29976920 | ||
| Neuronal clearance of amyloid-β by endocytic receptor LRP1. | Q29977780 | ||
| Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease | Q30444790 | ||
| Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation | Q30586714 | ||
| Homocysteine metabolism | Q33711793 | ||
| Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier | Q33928434 | ||
| Plasma homocysteine as a risk factor for dementia and Alzheimer's disease | Q33957399 | ||
| Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view | Q34268430 | ||
| Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology | Q34738708 | ||
| Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? | Q35175404 | ||
| Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles | Q35185115 | ||
| Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy | Q36103875 | ||
| The cerebral beta-amyloid angiopathies: hereditary and sporadic | Q36448518 | ||
| Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. | Q37079075 | ||
| Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease | Q37613107 | ||
| LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. | Q40528558 | ||
| SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides | Q40836314 | ||
| Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. | Q46675546 | ||
| Is Alzheimer's disease an apolipoprotein E amyloidosis? | Q46974350 | ||
| Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels | Q46975024 | ||
| P433 | issue | 1 | |
| P921 | main subject | cerebral amyloid angiopathy | Q191562 |
| P304 | page(s) | 29-35 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | High levels of homocysteine results in cerebral amyloid angiopathy in mice | |
| P478 | volume | 43 |
| Q99608983 | Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation |
| Q38779069 | Animal Models of Vascular Cognitive Impairment and Dementia (VCID). |
| Q47280362 | Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology |
| Q54979717 | Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy. |
| Q91410845 | Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35 |
| Q37104293 | Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction |
| Q38896912 | Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide. |
| Q83229361 | Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity |
| Q35158376 | Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? |
| Q91246348 | Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease |
| Q28068353 | Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease |
| Q41353649 | Sleep mediates the association between homocysteine and oxidative status in mild cognitive impairment |
Search more.